{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-003940","form_type":"8-K","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.970231+00:00","generated_at":"2026-06-07T02:06:47.389680+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"Catalyst Pharmaceuticals posts corporate presentation; no new material financial or business updates disclosed","bullets":["Filed an 8-K on January 8, 2024, announcing a corporate presentation posted to its website for investor discussions.","Presentation cover page and safe harbor language provided; no specific financial results, pipeline updates, or material events included.","No earnings, M&A, leadership changes, debt, litigation, cyber, dividend, or regulatory actions reported in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-003940","json":"https://secwatch.observer/filing/0001193125-24-003940.json","markdown":"https://secwatch.observer/filing/0001193125-24-003940.md","text":"https://secwatch.observer/filing/0001193125-24-003940.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312524003940/0001193125-24-003940-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312524003940/d108681d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:06:47.389680+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}